The Effect of Disease-associated Mutations on the Folding Pathway of Human Prion Protein*

Propagation of transmissible spongiform encephalopathies is believed to involve the conversion of cellular prion protein, PrPC, into a misfolded oligomeric form, PrPSc. An important step toward understanding the mechanism of this conversion is to elucidate the folding pathway(s) of the prion protein. We reported recently (Apetri, A. C., and Surewicz, W. K. (2002) J. Biol. Chem. 277, 44589-44592) that the folding of wild-type prion protein can best be described by a three-state sequential model involving a partially folded intermediate. Here we have performed kinetic stopped-flow studies for a number of recombinant prion protein variants carrying mutations associated with familial forms of prion disease. Analysis of kinetic data clearly demonstrates the presence of partially structured intermediates on the refolding pathway of each PrP variant studied. In each case, the partially folded state is at least one order of magnitude more populated than the fully unfolded state. The present study also reveals that, for the majority of PrP variants tested, mutations linked to familial prion diseases result in a pronounced increase in the thermodynamic stability, and thus the population, of the folding intermediate. These data strongly suggest that partially structured intermediates of PrP may play a crucial role in prion protein conversion, serving as direct precursors of the pathogenic PrPSc isoform.

[1]  H Nakatani,et al.  Test reactions for a stopped-flow apparatus. Reduction of 2,6-dichlorophenolindophenol and potassium ferricyanide by L-ascorbic acid. , 1978, Analytical biochemistry.

[2]  S. Prusiner Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[3]  S. Prusiner,et al.  Separation and properties of cellular and scrapie prion proteins. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. W. Bolen,et al.  Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. , 1988, Biochemistry.

[5]  B. Caughey,et al.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.

[6]  L. Hood,et al.  Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. , 1993, Biochemistry.

[7]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Khorasanizadeh,et al.  Folding and stability of a tryptophan-containing mutant of ubiquitin. , 1993, Biochemistry.

[9]  P. Roller,et al.  Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity , 1993, Protein science : a publication of the Protein Society.

[10]  P. Lansbury,et al.  Cell-free formation of protease-resistant prion protein , 1994, Nature.

[11]  R J Fletterick,et al.  Structural clues to prion replication. , 1994, Science.

[12]  C. Weissmann Molecular biology of transmissible spongiform encephalopathies , 1996, Progress in brain research.

[13]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[14]  M. Oliveberg,et al.  Transient aggregates in protein folding are easily mistaken for folding intermediates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K Wüthrich,et al.  NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.

[16]  F E Cohen,et al.  A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. , 1997, Journal of molecular biology.

[17]  J. Kelly,et al.  Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases. , 1997, Structure.

[18]  Christopher M. Dobson,et al.  Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.

[19]  K Wüthrich,et al.  Human prion proteins expressed in Escherichia coli and purified by high‐affinity column refolding , 1997, FEBS letters.

[20]  H. Roder,et al.  Kinetic role of early intermediates in protein folding. , 1997, Current opinion in structural biology.

[21]  M. Oliveberg,et al.  High-energy channeling in protein folding. , 1997, Biochemistry.

[22]  P E Wright,et al.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Bürkle,et al.  Overexpression of Nonconvertible PrPcΔ114–121 in Scrapie-Infected Mouse Neuroblastoma Cells Leads to trans-Dominant Inhibition of Wild-Type PrPSc Accumulation , 1998, Journal of Virology.

[24]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[25]  W. Surewicz,et al.  Familial Mutations and the Thermodynamic Stability of the Recombinant Human Prion Protein* , 1998, The Journal of Biological Chemistry.

[26]  S. Radford,et al.  Rapid folding with and without populated intermediates in the homologous four-helix proteins Im7 and Im9. , 1999, Journal of molecular biology.

[27]  S. Marqusee,et al.  Confirmation of the hierarchical folding of RNase H: a protein engineering study , 1999, Nature Structural Biology.

[28]  J. Collinge,et al.  Structural mobility of the human prion protein probed by backbone hydrogen exchange , 1999, Nature Structural Biology.

[29]  R. Glockshuber,et al.  Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. , 1999, Biochemistry.

[30]  W. Surewicz,et al.  Membrane Environment Alters the Conformational Structure of the Recombinant Human Prion Protein* , 1999, The Journal of Biological Chemistry.

[31]  R. Glockshuber,et al.  Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates , 1999, Nature Structural Biology.

[32]  B. Caughey Transmissible spongiform encephalopathies, amyloidoses and yeast prions: Common threads? , 2000, Nature Medicine.

[33]  J. Weissman,et al.  Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro- converted Sup35 protein. , 2000, Science.

[34]  T. Sosnick,et al.  Distinguishing between two-state and three-state models for ubiquitin folding. , 2000 .

[35]  A. Fersht A kinetically significant intermediate in the folding of barnase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Roberts,et al.  Prions of yeast as heritable amyloidoses. , 2000, Journal of structural biology.

[37]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Takei,et al.  Absence of stable intermediates on the folding pathway of barnase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Chesebro,et al.  Transmissible spongiform encephalopathies and prion protein interconversions. , 2001, Advances in virus research.

[40]  W. Surewicz,et al.  On the Mechanism of α-Helix to β-Sheet Transition in the Recombinant Prion Protein† , 2001 .

[41]  J. Collinge Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.

[42]  Suzette Apriola Prion protein diversity and disease in the transmissible spongiform encephalopathies , 2001 .

[43]  B. Chesebro,et al.  Sulfated glycans and elevated temperature stimulate PrPSc‐dependent cell‐free formation of protease‐resistant prion protein , 2001, The EMBO journal.

[44]  F. Cohen,et al.  Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation. , 2002, Journal of molecular biology.

[45]  W. Surewicz,et al.  Disease-associated F198S Mutation Increases the Propensity of the Recombinant Prion Protein for Conformational Conversion to Scrapie-like Form* , 2002, The Journal of Biological Chemistry.

[46]  T. Sosnick,et al.  Fast and slow intermediate accumulation and the initial barrier mechanism in protein folding. , 2002, Journal of molecular biology.

[47]  C. Dobson,et al.  Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme , 2002, Nature Structural Biology.

[48]  S. Prusiner,et al.  Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc? , 2002, Biochemistry.

[49]  W. Surewicz,et al.  Kinetic Intermediate in the Folding of Human Prion Protein* , 2002, The Journal of Biological Chemistry.

[50]  Susan Lindquist,et al.  Prions as protein-based genetic elements. , 2002, Annual review of microbiology.

[51]  S. Ferreira,et al.  Folding Intermediates of the Prion Protein Stabilized by Hydrostatic Pressure and Low Temperature* , 2003, Journal of Biological Chemistry.

[52]  E. M. Jones,et al.  Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: Structural clues for prion propagation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  T. Kiefhaber,et al.  Evidence for sequential barriers and obligatory intermediates in apparent two-state protein folding. , 2003, Journal of molecular biology.

[54]  A. Fersht,et al.  The kinetic pathway of folding of barnase. , 2003, Journal of molecular biology.